Herpes Zoster Aspectos clínicos y terapéuticos
Abstract
Se prensentasn algunos aspectos históricos respecto al descubrimiento del agente atiológico del Herpes Zoster. Así mismo, se resaltan sus características clínicas y secuelas en los diferentes sistemas afectados. Se indican pautas de tratamiento para lograr un manejo correcto y minimizar la aparición de sus complicaciones.
Author Biography
Laureano Augusto Osario Gutiérrez, Instituto de Ciencias de la Salud
Dermatólogo, Instituto de Ciencias de la Salud, Medellín.
References
2. McGrary ML, Severson J, Tryng SK. Varicella Zoster Virus. J Am Acad Dermatol 1999; 1-10.
https://doi.org/10.1016/S0190-9622(99)70398-1
3. Ragazzino MW, Melton LJ, Kurland LT, et al.Risk of cancer after Herpes Zoster - a population based Study.N Engl J Med 1982; 307-393-397.
https://doi.org/10.1056/NEJM198208123070701
4. Sterling JC, Kurts JB. Viral infections. En: Textbook of Dermatology, 6a. ed.1998; 1015-1021.
5. Dolin R. Antiviral Drugs. En: Dermatology in Gene ral Medicine, 5a.ed.1999; 2837-2845.
6. Lee AT T. Clinics in Neurology. Herpes Zoster and Postherpetic Neuralgia. J Hong Kong Med Ass 1988; 40:295-298.
7. Hope-Simpson RE.Postherpetic Neuralgia.Herpes Zoster in general practice. J Roy Col Gen Practit 1975; 25:571-575.
8. Morton P, Thompson AN. Oral Acyclovir in the treatment of Herpes Zoster in General Practice. N Zealand Med J 1989; 102:863.
9. Evans TY, Tyring SK. Advances in antiviral therapy inDermatology. En:DermatologicClinic1999(16- 2):409-420.
https://doi.org/10.1016/S0733-8635(05)70022-X
10. Weller S, Blum MR, Doucette M, et al.Pharma cokinetics of the Acyclovir pro-drug Valaciclovir after escalating single and multiple dose administration to normal volunteers. Clin Pharmacol Therap1993; 54:595-605.
https://doi.org/10.1038/clpt.1993.196
11. Wood MJ, Kukla S, Fiddian AP et al. Treatment of Acute Herpes Zoster: Effect of Early (<48h) versus late (48-72h) Therapy with Acyclovir and Valacyclovir on Prolonged Pain. J lnfect Dis 1998; 178(suppl 1):S81-84.
https://doi.org/10.1086/514271
12. Beutner KR, Friedman DJ, Forspaniak C et al. Therapy for Herpes Zoster in lmmunocompetent Adults. Antimicrobial Agents and Chemotherapy 1995; 1546-1553.
https://doi.org/10.1128/AAC.39.7.1546
13. Grand DM, Mauskopf JA, Bell L, et al.Comparison of Valacyclovir and Acyclovir for Treatment of Her pes Zoster in lmmunocompetent Patiens over 50 years of Age: A Costs Consequence Model. Phar macotherapy 1997; 17:333-341.
14. Perry CM, Foulds D. Valacyclovir. A Review of its Antiviral Activity, Pharmacokinetics Properties and Therapeutics Efficacy in Herpesvirus lnfections. Drugs 1996; 52:754-772.
https://doi.org/10.2165/00003495-199652050-00009
15. Hayden FG. Antiviral Agents. En: Pharmacological Basis of Therapeutics. Goodman and Gillman·s (eds), 9a. ed. 1966; 1191-1223.
16. Harris BD, Adal KA, Tomacki KJ.New and Emerging Therapies in lnfectious Diseases.En: Dermatologic Clinic 2000 (18-1):31-37.
https://doi.org/10.1016/S0733-8635(05)70144-3
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |